The Lancet has retracted a 49-year-old commentary that was used in a lawsuit to support the safety of talc products. The reason for the retraction is the discovery that the author of the comment was a paid consultant to Johnson & Johnson at the time of its publication. The comment was unsigned. The article also addresses the topic of liver cancer prediction and genetic testing fraud.